These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction. He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506 [TBL] [Abstract][Full Text] [Related]
4. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease. He X; Zeng H; Chen JX J Cell Physiol; 2019 Mar; 234(3):2252-2265. PubMed ID: 30132870 [TBL] [Abstract][Full Text] [Related]
5. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction. Tona F; Montisci R; Iop L; Civieri G Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251 [TBL] [Abstract][Full Text] [Related]
6. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356 [TBL] [Abstract][Full Text] [Related]
8. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction. Frisk M; Le C; Shen X; Røe ÅT; Hou Y; Manfra O; Silva GJJ; van Hout I; Norden ES; Aronsen JM; Laasmaa M; Espe EKS; Zouein FA; Lambert RR; Dahl CP; Sjaastad I; Lunde IG; Coffey S; Cataliotti A; Gullestad L; Tønnessen T; Jones PP; Altara R; Louch WE J Am Coll Cardiol; 2021 Feb; 77(4):405-419. PubMed ID: 33509397 [TBL] [Abstract][Full Text] [Related]
9. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. Paulus WJ; Dal Canto E JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577 [TBL] [Abstract][Full Text] [Related]
10. Coronary Microcirculation in Heart Failure with Preserved Systolic Function. Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878 [TBL] [Abstract][Full Text] [Related]
11. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Taqueti VR; Solomon SD; Shah AM; Desai AS; Groarke JD; Osborne MT; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF Eur Heart J; 2018 Mar; 39(10):840-849. PubMed ID: 29293969 [TBL] [Abstract][Full Text] [Related]
12. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs? Cornuault L; Rouault P; Duplàa C; Couffinhal T; Renault MA Front Physiol; 2022; 13():906272. PubMed ID: 35874523 [TBL] [Abstract][Full Text] [Related]
13. Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice. Su H; Zeng H; He X; Zhu SH; Chen JX J Am Heart Assoc; 2020 Sep; 9(18):e017176. PubMed ID: 32865093 [TBL] [Abstract][Full Text] [Related]
14. Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia. He X; Zeng H; Chen JX Int J Cardiol; 2016 Jul; 215():349-57. PubMed ID: 27128560 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Ljung Faxén U; Fermer ML; Broberg MA; Gan LM; Lund LH Eur Heart J; 2018 Oct; 39(37):3439-3450. PubMed ID: 30165580 [TBL] [Abstract][Full Text] [Related]
16. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Seferović PM; Paulus WJ Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006 [TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Yang JH; Obokata M; Reddy YNV; Redfield MM; Lerman A; Borlaug BA Eur J Heart Fail; 2020 Mar; 22(3):432-441. PubMed ID: 31840366 [TBL] [Abstract][Full Text] [Related]
19. A Sex-Specific Role of Endothelial Sirtuin 3 on Blood Pressure and Diastolic Dysfunction in Female Mice. Zeng H; He X; Chen JX Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371209 [TBL] [Abstract][Full Text] [Related]
20. PDE9A Inhibition Improves Coronary Microvascular Rarefaction and Left Ventricular Diastolic Dysfunction in the ZSF1 Rat Model of HFpEF. Fopiano KA; Zhazykbayeva S; El-Battrawy I; Buncha V; Pearson WM; Hardell DJ; Lang L; Hamdani N; Bagi Z Microcirculation; 2024 Nov; 31(8):e12888. PubMed ID: 39325678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]